Literature DB >> 3178043

Delayed reconstructive surgery for complex enterocutaneous fistulae.

R L Conter1, L Roof, J J Roslyn.   

Abstract

A retrospective analysis was performed of 51 consecutive patients with complex enterocutaneous fistulae who underwent delayed reconstructive surgery. In this group of seriously ill patients, gastrointestinal continuity was restored in 94 per cent and the mortality rate was 4 per cent. The authors believe that patients with multiple or recurrent fistulae, or those associated with large abdominal wall defects can be managed through a staged multi-disciplined approach in which definitive surgery is deferred beyond the usually recommended period of six weeks.

Entities:  

Mesh:

Year:  1988        PMID: 3178043

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  4 in total

1.  Enterocutaneous fistula and small bowel evisceration of twenty-five years' duration: successful surgical and nutritional management.

Authors:  Vihas Patel; Kris M Mogensen; Selwyn O Rogers; Malcolm K Robinson
Journal:  Dig Dis Sci       Date:  2007-03-15       Impact factor: 3.199

2.  Effect of Oral ω3-Polyunsaturated Fatty Acids as a Complement Management to Control Fistula Output and Inflammation in Patients With Digestive Fistula.

Authors:  José Luis Martínez-Ordaz; Ilka Boscó-Gárate; Arturo Cérbulo-Vázquez; Lourdes Arriaga-Pizano; Isabel Wong-Baeza; Patricio Sánchez-Fernandez; Constantino López-Macías; Armando Isibasi; Eduardo Ferat-Osorio
Journal:  J Gastrointest Surg       Date:  2016-12-01       Impact factor: 3.452

3.  Small bowel enterocutaneous fistulae: the merits of early surgery.

Authors:  Manoj Gupta; Pankaj Sonar; Rahul Kakodkar; Vinay Kumaran; Ravi Mohanka; Aravinder Soin; Samirn Nundy
Journal:  Indian J Surg       Date:  2008-12-23       Impact factor: 0.656

4.  Treatment strategies in 135 consecutive patients with enterocutaneous fistulas.

Authors:  Ruben G J Visschers; Steven W M Olde Damink; Bjorn Winkens; Peter B Soeters; Wim G van Gemert
Journal:  World J Surg       Date:  2008-03       Impact factor: 3.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.